Novartis dodges monopolisation lawsuit
A federal judge in Massachusetts has dismissed a lawsuit alleging Novartis Pharmaceuticals tried to monopolise the market for a leukemia drug.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10